Hosokawa Micron (6277) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
3 Oct, 2025Executive summary
Net sales reached a record-high ¥85.4 billion, up 7.4% year-over-year, and operating profit rose 4.0% to ¥8.2 billion.
Ordinary profit increased 10.7% to ¥9.2 billion, but net profit declined 6.5% to ¥5.6 billion due to extraordinary losses.
Gross profit margin improved by 0.9pp to 35.1% as price hikes offset raw material cost increases.
Financial highlights
Bookings decreased 1.5% year-over-year to ¥77.7 billion, while net sales rose 7.4% to ¥85.4 billion.
Gross profit increased to ¥29.9 billion; SG&A expenses rose 12.7% to ¥21.7 billion.
Comprehensive income dropped to ¥5.2 billion from ¥9.9 billion year-over-year.
Earnings per share (basic) was ¥371.99, down from ¥382.75 the previous year.
Cash and cash equivalents at year-end were ¥26.9 billion.
Outlook and guidance
FY2025 forecast: net sales ¥83.0 billion (down 2.8%), operating profit ¥6.5 billion (down 21.5%), net profit ¥5.1 billion (down 8.6%).
Dividend forecast for FY2025 is ¥120 per share, maintaining a high payout ratio of 34.8%.
Cautious investment climate expected, especially in rechargeable battery markets; temporary cost increases anticipated.
Earnings per share forecasted at ¥344.96 for the next fiscal year.
Latest events from Hosokawa Micron
- Sales up, profits down on higher costs and one-time loss; FY2026 outlook steady.6277
Q1 20266 Feb 2026 - Sales and profits fell, but comprehensive income surged; FY2026 profit recovery expected.6277
Q4 20257 Nov 2025 - Strong sales growth and higher profits, but full-year outlook signals profit decline.6277
Q3 20243 Oct 2025 - Sales and profits declined, but comprehensive income soared on currency gains; major merger completed.6277
Q1 20253 Oct 2025 - Net sales and operating profit fell, but interim profit hit a record high amid stable bookings.6277
Q2 20253 Oct 2025 - Profit rose on lower extraordinary losses despite sales decline; treasury share buyback approved.6277
Q3 20253 Oct 2025